Literature DB >> 24830536

Left ventricular hypertrophy, abnormal ventricular geometry and relative wall thickness are associated with increased risk of stroke in hypertensive patients among the Han Chinese.

Shuxia Wang1, Hao Xue2, Yubao Zou3, Kai Sun3, Chunyan Fu3, Hu Wang3, Rutai Hui3.   

Abstract

Our study aimed to explore whether left ventricular hypertrophy (LVH), abnormal LV geometry and relative wall thickness (RWT) are associated with an increased risk of stroke in a hypertensive Chinese population. This study included 462 stroke patients and 3808 non-stroke hypertensive patients. LVH was diagnosed using the criteria of LV mass ⩾49.2 g m(-2.7) for men and 46.7 g m(-2.7) for women. A partition value of 0.43 was used for RWT. LV geometric patterns (normal, concentric remodeling, concentric or eccentric hypertrophy) were calculated according to LVH and RWT. Logistic regression analyses were used to determine the odds ratio (OR) and 95% confidence intervals (CI) of LVH, LV geometry abnormality and RWT for stroke. Our study suggested that LVH was associated with increased stroke risk (adjusted OR, 1.52; 95% CI, 1.25-1.85; multivariate-adjusted OR, 1.43; 95% CI, 1.16-1.75) and that concentric hypertrophy carried the highest risk of stroke (adjusted OR, 1.62; 95% CI, 1.21-2.17), followed by eccentric hypertrophy (adjusted OR, 1.51; 95% CI, 1.12-2.03), with concentric remodeling ranked third (adjusted OR, 1.34; 95% CI, 1.01-1.80). RWT was associated with an increased risk of stroke and was independent of LVMI and other risk factors for stroke (adjusted OR, 3.97; 95% CI, 1.10-14.34). Our observations in Chinese patients with hypertension indicated that LVH was an important risk factor for stroke, LV geometry abnormality was related to the presence of stroke, concentric hypertrophy carried the highest risk of stroke in cases of abnormal LV geometry and that RWT was also a risk factor for stroke and was independent of LVMI and other stroke risk factors.

Entities:  

Mesh:

Year:  2014        PMID: 24830536     DOI: 10.1038/hr.2014.88

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  11 in total

1.  Left ventricular layer function in hypertension assessed by myocardial strain rate using novel one-beat real-time three-dimensional speckle tracking echocardiography with high volume rates.

Authors:  Maki Saeki; Noriaki Sato; Masanori Kawasaki; Ryuhei Tanaka; Maki Nagaya; Takatomo Watanabe; Koji Ono; Toshiyuki Noda; Michael R Zile; Shinya Minatoguchi
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

2.  Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study.

Authors:  Piotr Dobrowolski; Aleksander Prejbisz; Anna Klisiewicz; Elżbieta Florczak; Justyna Rybicka; Andrzej Januszewicz; Piotr Hoffman
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

3.  Intraventricular pressure gradients change during the development of left ventricular hypertrophy: Effect of salvianolic acid B and beta-blocker.

Authors:  Danfu Ma; Ahmed S Mandour; Tomohiko Yoshida; Katsuhiro Matsuura; Kazumi Shimada; Pitipat Kitpipatkun; Akiko Uemura; Mayumi Ifuku; Ken Takahashi; Ryou Tanaka
Journal:  Ultrasound       Date:  2021-02-04

4.  Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage.

Authors:  Elizabeth E Moore; Omair A Khan; Niranjana Shashikumar; Kimberly R Pechman; Dandan Liu; Susan P Bell; Sangeeta Nair; James G Terry; Katherine A Gifford; Adam W Anderson; Bennett A Landman; Kaj Blennow; Henrik Zetterberg; Timothy J Hohman; John Jeffrey Carr; Angela L Jefferson
Journal:  Stroke       Date:  2021-10-27       Impact factor: 7.914

5.  The association of metabolic syndrome with left ventricular mass and geometry in community-based hypertensive patients among Han Chinese.

Authors:  Shuxia Wang; Kangxing Song; Xiyun Guo; Hao Xue; Nina Wang; Jingzhou Chen; Yubao Zou; Kai Sun; Hu Wang; Jinggui He; Rutai Hui
Journal:  J Res Med Sci       Date:  2015-10       Impact factor: 1.852

6.  Cardiac Hypertrophy is Positively Regulated by MicroRNA‑24 in Rats

Authors:  Juan Gao; Min Zhu; Rui-Feng Liu; Jian-Shu Zhang; Ming Xu
Journal:  Chin Med J (Engl)       Date:  2018-06-05       Impact factor: 2.628

7.  Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.

Authors:  Dan Liu; Kai Hu; Marie Schmidt; Jonas Müntze; Octavian Maniuc; Daniel Gensler; Daniel Oder; Tim Salinger; Frank Weidemann; Georg Ertl; Stefan Frantz; Christoph Wanner; Peter Nordbeck
Journal:  Clin Res Cardiol       Date:  2018-05-24       Impact factor: 5.460

8.  Echocardiographic Abnormalities and Determinants of 1-Month Outcome of Stroke Among West Africans in the SIREN Study.

Authors:  Abiodun M Adeoye; Bruce Ovbiagele; Joshua O Akinyemi; Okechukwu S Ogah; Rufus Akinyemi; Mulugeta Gebregziabher; Kolawole Wahab; Adekunle G Fakunle; Adeseye Akintunde; Oladimeji Adebayo; Akinyemi Aje; Hemant K Tiwari; Donna Arnett; Francis Agyekum; Lambert T Appiah; Ganiyu Amusa; Taiwo O Olunuga; Akpa Onoja; Fred S Sarfo; Albert Akpalu; Carolyn Jenkins; Daniel Lackland; Lukman Owolabi; Morenikeji Komolafe; Moyinoluwalogo M Faniyan; Oyedunni Arulogun; Reginald Obiako; Mayowa Owolabi
Journal:  J Am Heart Assoc       Date:  2019-05-30       Impact factor: 5.501

9.  Relationship of a new anthropometric index with left ventricular hypertrophy in hypertensive patients among the Han Chinese.

Authors:  Shuang Cai; Jing Dong; Bokai Cheng; Anhang Zhang; Jin Sun; Man Li; Yongkang Su; Qiligeer Bao; Ping Zhu; Shuxia Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-01-26       Impact factor: 2.298

10.  Blood pressure variability and night-time dipping assessed by 24-hour ambulatory monitoring: Cross-sectional association with cardiac structure in adolescents.

Authors:  Lucy J Goudswaard; Sean Harrison; Daniel Van De Klee; Nishi Chaturvedi; Debbie A Lawlor; George Davey Smith; Alun D Hughes; Laura D Howe
Journal:  PLoS One       Date:  2021-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.